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Drug Induced T-Cell Dyscrasia Mimicking Granulomatous Mycosis Fungoides
Kelly L. Reed, DO and Christian W. Oram, DO

Lehigh Valley Health Network, Allentown, Pennsylvania

Case Presentation:

Discussion:
Figures 1-3: Scattered, pink to violaceous papules located on the face, back and flank

Patient: 47 year-old Indian male.
History of Present Illness: The patient presented with an
eight-month history of pruritic papules on the arms and legs, which gradually
spread to involve the face. The lesions were not responsive to topical
corticosteroids alone. He denied systemic symptoms or new medications.
However, he admitted to beginning new hair loss regimen, with an oral
dietary supplement (containing vitamins B3, D and E, biotin, saw palmetto
and nettle root). The patient was instructed to discontinue this supplement
upon presentation and had complete clearance of his rash within two weeks.
Medical/Surgical History: Nephrolithiasis, tinea pedis
Family History: Negative for skin cancer or hematological
malignancy

Figure 1

Medications: Hair Revitalizing Complex, halobetasol propionate
0.05% ointment, econazole nitrate 1% cream, miconazole topical powder
Previous Medications: Fluoruracil 5%, doxycycline, clobetasol
proprionate 0.05% cream
Current Treatment: Halobetasol propionate 0.05% ointment,
CeraVe moisturizing cream
Physical Examination: The patient presents with multiple
scattered, pink to violaceous papules involving the glabella, eyelids,
periorbital areas, arms and legs. There is no palpable lymphadenopathy.
Laboratory Data: (08/25/2015) T-cell receptor (TCR) gamma gene
rearrangement by PCR positive.
Biopsy: Advanced Dermatology Associates, LTD (AD15-09941,
08/25/2015) Right temple: “Mycosis fungoides. There are nodular
lymphohistiocytic infiltrates in the superficial half of the dermis that, on
multiple sections, appear to be perifollicular. Lymphocytes are also scattered
and clustered in the epidermis, and within follicular epithelium. IHC stains
demonstrate a significant loss of CD7 positivity overall (with less than 10%
of cells staining), when compared with CD2, CD3, and CD5. Intraepidermal
lymphocytes are entirely CD7-. CD4 and CD8 stains demonstrate an
overall helper:suppressor ratio of greater than 10:1, while intraepidermal
lymphocytes are almost entirely CD4+/CD8-. CD45RB and CD45RO
highlight all lymphocytes in a roughly equal fashion. The immunostains
also demonstrate intraepidermal lymphocytes to be conspicuously aligned
in the basal layer across the surface and also down the sides of follicular
epithelium.

Figure 2

Figure 3

Figures 4-6: Punch biopsy of the right temple demonstrating a nodular, lymphohistiocytic infiltrate in the
superficial dermis with lymphocytes perifollicularly, tagging the basal layer, and within epidermis
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Diagnosis: Drug Induced T-Cell Dyscrasia Mimicking
Granulomatous Mycosis Fungoides.
Follow-up: The patient was instructed to avoid the dietary supplement

and followed closely. He had no evidence of recurrence at six months follow-up.

T-cell dyscrasia is a term used to encompass a group of disorders that often present with a
cutaneous infiltrate, exhibiting cytologic and histopathological atypia, which may be associated
with a clonal T-cell population. These disorders may mimick other entities both clinically and
histopathologically, such as mycosis fungoides (MF) or cutaneous T-cell lymphoma. Clinical
characteristics of drug-induced MF-like lesions can be quite variable, ranging from discreet
papules, plaques or nodules to a more diffuse, maculopapular eruption or rarely, erythroderma.
Descriptions of this disease have appeared in the literature under various terms, such as drugassociated pseudolymphoma and drug-associated reversible T-cell dyscrasia. The defining
characteristics of such cases are that of an atypical lymphocytic cutaneous proliferation with
findings similar to MF in their histopathological, phenotypic and molecular profiles. By definition,
the eruption may begin weeks to years after initiation of a medication with complete resolution
upon its discontinuation and worsening or recurrence with medication re-challenge. Medications
reported in the literature that cause similar eruptions include: antihistamines, anticonvulsants,
antipsychotics, serotonin reuptake inhibitors, penicillin, dapsone, nitrofurantoin, vancomycin,
rifampin, beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors
and many more. Contrarily, over the counter medications and supplements, as in our patient’s
case, have rarely been reported as causative agents. The proposed pathogenesis of this entity
is that of antigenic stimulation from the medication resulting in aberrant T-cell proliferation.
Histopathological findings are variable and may simulate both interstitial granulomatous disease
as well as MF, as reported by Magro et al. Features may include: superficial and mid dermal
atypical lymphocytic associated with a palisading histiocytic infiltrate, epidermotropism, elevated
CD4:CD8 ratio and loss of CD7. Cases have been reported in association with monoclonal T-cell
populations in both biopsy specimens and peripheral blood, however the majority are polyclonal.
Patients are reported to have complete resolution of their skin findings in as early as one to
twelve weeks of medication discontinuation. In many cases no recurrence has been reported in
up to three years, according to one study. These patients should avoid the inciting medication
and should be followed to ensure long-term resolution of their disease. It is unknown if the
antigenic stimulation predisposes them to the development of lymphoma in the future.
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